查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区分子诊断市场预测 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户
市场调查报告书
商品编码
1452575

2030 年亚太地区分子诊断市场预测 - 区域分析 - 按疾病领域、技术、产品和服务以及最终用户

Asia Pacific Molecular Diagnostics Market Forecast to 2030 - Regional Analysis - by Disease Area, Technology, Product and Services, and End User
出版日期: | 出版商: The Insight Partners | 英文 167 Pages | 订单完成后即时交付

价格

亚太分子诊断市场预计将从2022年的34.7848亿美元成长到2030年的96.9811亿美元。预计2022年至2030年CAGR为13.7%。

分子诊断技术的进步推动亚太分子诊断市场

分子诊断技术和平台正在应用于解剖学和临床病理学的所有领域。与疾病相关的 DNA 或 RNA 序列，包括单核苷酸多态性、缺失、重排和插入，可在分子诊断测试中检测到。 COVID-19出现后，分子诊断得到了进一步的改进。传统上，CT扫描、血液学检测和RT-PCR用于检测。随着 2020 年 COVID-19 病例的快速增长，对快速、精确的检测平台的需求激增，以克服传统检测的缺点。电脑断层扫描 (CT) 是一种成本密集型检查，可能并非所有医院都能提供，无法检测无症状患者的病毒感染和其他疾病。广泛使用的RT-PCR也耗时且昂贵，无法检测感染早期的低病毒量。因此，研究人员开发了检测 SARS-CoV-2 的新方法，这种方法更快、更具成本效益。逆转录环介导等温扩增 (RT-LAMP)、基于微阵列的检测、基于适体的诊断、SHERLOCK、SHERLOCKv2、FET 生物感测器、基于细胞的电位诊断和分子印迹技术是新型分子诊断的一些例子为COVID-19 诊断所开发的技术。在过去几年中，FDA 报告显示分子检测、抗原依赖性检测和血清学检测的进步已获得批准。不同国家的科学界为管理 COVID-19 大流行和降低死亡率而共同努力，使整个分子工具和诊断领域受益，这可能会在未来为分子诊断市场创造重大机会。

亚太地区分子诊断市场概况

亚太地区包括马来西亚、泰国、印度、新加坡、菲律宾、越南、印尼、中国、日本、澳洲、韩国和亚太地区其他地区。老年人口的增加、癌症病例的增加、技术的进步以及新创公司、生物技术和生物製药公司数量的增加正在推动该地区的分子诊断市场。此外，该地区研究活动的增加以及提高癌症护理品质的协会或组织的存在有助于分子诊断市场的成长。

亚太地区分子诊断市场收入及 2030 年预测（百万美元）

亚太地区分子诊断市场区隔

亚太地区分子诊断市场分为疾病领域、技术、产品和服务、最终用户和国家。

根据疾病领域，亚太分子诊断市场分为传染病、肿瘤、基因检测、心臟病、免疫系统疾病等。 2022 年，传染病细分市场占据亚太地区最大的分子诊断市场。

根据技术，亚太分子诊断市场分为聚合酶炼式反应（PCR）、原位杂交、等温核酸扩增技术（INAAT）、DNA定序和下一代定序（NGS）、DNA微阵列等。聚合酶链反应 (PCR) 领域在 2022 年占据亚太地区最大的分子诊断市场份额。聚合酶链反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。

根据产品和服务，亚太分子诊断市场分为检测和试剂盒、仪器、服务和软体。 2022 年，检测和试剂盒领域占据亚太地区最大的分子诊断市场。

根据最终用户，亚太地区分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构等。 2022 年，诊断实验室领域占据亚太地区最大的分子诊断市场。

依国家/地区划分，亚太地区分子诊断市场分为印度、新加坡、马来西亚、菲律宾、泰国、印尼、越南、中国、日本、澳洲、韩国和亚太地区其他地区。 2022年，中国将主导亚太分子诊断市场。

Abbott Laboratories、Agilent Technologies Inc、Thermo Fisher Scientific Inc、F. Hoffmann-La Roche Ltd、Qiagen NV、bioMerieux SA、Illumina Inc、Danaher、Siemens Healthineers AG、Novartis AG 和TBG Diagnostics Limited 是在这些领域运营的一些领先公司。亚太分子诊断市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区分子诊断市场格局

  • 概述
  • PEST分析
    • 亚太地区 PEST 分析

第 5 章：亚太地区分子诊断市场 - 主要产业动态

  • 主要市场驱动因素：
    • 新产品的开发和即时检测需求的增加
    • 相关疾病的盛行率激增
  • 市场限制
    • 与分子测试相关的局限性
  • 市场机会
    • 分子诊断技术的进步
  • 未来的趋势
    • 个性化医疗中的分子诊断
  • 影响分析：

第 6 章：分子诊断市场 - 亚太市场分析

  • 亚太地区分子诊断市场收入，2022 - 2030

第 7 章：亚太地区分子诊断市场 - 收入和 2030 年预测 - 按疾病领域

  • 概述
  • 2022 年和 2030 年亚太地区分子诊断市场收入份额（按疾病领域划分）（%）
  • 肿瘤学
  • 传染病
  • 基因检测
  • 心臟病
  • 免疫系统疾病
  • 其他的

第 8 章：亚太地区分子诊断市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年亚太地区分子诊断市场收入份额（按技术划分）（%）
  • 聚合酶炼式反应
  • 等温核酸扩增技术（INAAT）
  • DNA 定序和二代定序 (NGS)
  • DNA微阵列
  • 原位杂交 (ISH)
  • 其他的

第 9 章：亚太地区分子诊断市场 - 收入和 2030 年预测 - 按产品和服务

  • 概述
  • 2022 年和 2030 年亚太地区分子诊断市场收入份额（按产品和服务划分）（%）
  • 检测方法和试剂盒
  • 仪器
  • 服务和软体

第 10 章：亚太地区分子诊断市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年亚太地区分子诊断市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
  • 其他的

第 11 章：亚太地区分子诊断市场 - 国家分析

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 新加坡
  • 马来西亚
  • 菲律宾
  • 泰国
  • 印尼
  • 越南
  • 亚太地区其他地区

第 12 章：亚太地区分子诊断市场产业格局

  • 概述
  • 市场上公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 13 章：亚太地区分子诊断市场，主要公司概况

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • bioMerieux SA
  • Illumina Inc
  • Danaher
  • Siemens Healthineers AG
  • Novartis AG
  • TBG Diagnostics Limited

第 14 章：附录

Product Code: TIPRE00026008

The Asia Pacific molecular diagnostics market is expected to grow from US$ 3,478.48 million in 2022 to US$ 9,698.11 million by 2030. It is estimated to grow at a CAGR of 13.7% from 2022 to 2030.

Advancements in Molecular Diagnostics Technologies Fuels Asia Pacific Molecular Diagnostics Market

Molecular diagnostic techniques and platforms are being used in all areas of anatomic and clinical pathologies. DNA or RNA sequences that are associated with disease, including single nucleotide polymorphism, deletions, rearrangements, and insertions, can be detected in molecular diagnostic tests. Molecular diagnosis has undergone further improvements after the emergence of COVID-19. Conventionally, CT scans, hematological tests, and RT-PCR were in use for testing. As COVID-19 cases grew rapidly in 2020, the need for rapid, precise testing platforms surged to overcome the disadvantages of conventional testing. Computed tomography (CT), a cost-intensive procedure that may not be available in all hospitals, fails to detect viral infections and other diseases in asymptomatic patients. RT-PCR, which was widely used, was also time-consuming and expensive, and was unable to detect a low viral load during the early stages of infection. Consequently, researchers developed novel approaches to detect SARS-CoV-2, which were faster and more cost effective. Reverse transcription loop-mediated isothermal amplification (RT-LAMP), microarray-based detection, aptamer-based diagnosis, SHERLOCK, SHERLOCKv2, FET Biosensors, cell-based potentiometric diagnosis, and molecular imprinting technology are a few of the examples of novel molecular diagnostics techniques developed for COVID-19 diagnosis. In the last few years, FDA reports have indicated that advancements in molecular testing, antigen-dependent testing, and serological testing have been approved. Collaborative efforts by scientific communities in different countries to manage the COVID-19 pandemic and reduce the extent of mortality have benefited the overall molecular tools and diagnosis landscape, which is likely to create significant opportunities for the molecular diagnostics market in the future.

Asia Pacific Molecular Diagnostics Market Overview

Asia Pacific includes Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing cancer cases, growing technological advancements, and increasing number of startups, biotechnology, and biopharmaceutical companies are driving the molecular diagnostics market in this region. Moreover, the rise in research activities in the region and the presence of associations or organizations enhancing the quality of care in cancer contribute to the molecular diagnostics market growth.

Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Molecular Diagnostics Market Segmentation

The Asia Pacific molecular diagnostics market is segmented into disease area, technology, product and services, end user, and country.

Based on disease area, the Asia Pacific molecular diagnostics market is segmented into infectious disease, oncology, genetic testing, cardiac diseases, immune system disorders, and others. The infectious disease segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on technology, the Asia Pacific molecular diagnostics market is segmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarrays, and others. The polymerase chain reaction (PCR) segment registered the largest Asia Pacific molecular diagnostics market share in 2022. The polymerase chain reaction (PCR) is further sub segmented into RT-PCR, qPCR, multiplex PCR, and others.

Based on product and services, the Asia Pacific molecular diagnostics market is segmented into assays and kits, instruments, and services and software. The assays and kits segment registered the largest Asia Pacific molecular diagnostics market share in 2022.

Based on end users, the Asia Pacific molecular diagnostics market is segmented into diagnostic laboratories, hospitals and clinics, research and academic institutes, and others. The diagnostic laboratories segment held the largest Asia Pacific molecular diagnostics market share in 2022.

Based on country, the Asia Pacific molecular diagnostics market has been categorized into India, Singapore, Malaysia, Philippines, Thailand, Indonesia, Vietnam, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular diagnostics market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Thermo Fisher Scientific Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, bioMerieux SA, Illumina Inc, Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are some of the leading companies operating in the Asia Pacific molecular diagnostics market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Molecular Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis

5. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
    • 5.1.2 Surging Prevalence of Associated Diseases
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Molecular Testing
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Molecular Diagnostics Technologies
  • 5.4 Future Trends
    • 5.4.1 Molecular Diagnostics in Personalized Medicine
  • 5.5 Impact Analysis:

6. Molecular Diagnostics Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

  • 7.1 Overview
  • 7.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Infectious Disease
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Genetic Testing: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Cardiac Diseases
    • 7.6.1 Overview
    • 7.6.2 Cardiac Diseases: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Immune System Disorders
    • 7.7.1 Overview
    • 7.7.2 Immune System Disorders: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Overview
    • 8.3.2 PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 RT-PCR
        • 8.3.2.1.1 Overview
    • 8.3.3 RT-PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.3.1 qPCR
        • 8.3.3.1.1 Overview
    • 8.3.4 PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.4.1 Multiplex PCR
        • 8.3.4.1.1 Overview
    • 8.3.5 Multiplex PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.5.1 Others
        • 8.3.5.1.1 Overview
    • 8.3.6 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Overview
    • 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
    • 8.5.1 Overview
    • 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 DNA Microarrays
    • 8.6.1 Overview
    • 8.6.2 DNA Microarrays: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 In-Situ Hybridization (ISH)
    • 8.7.1 Overview
    • 8.7.2 In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 9.1 Overview
  • 9.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 9.3 Assays and Kits
    • 9.3.1 Overview
    • 9.3.2 Assays and Kits: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Instruments
    • 9.4.1 Overview
    • 9.4.2 Instruments: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Services and Software
    • 9.5.1 Overview
    • 9.5.2 Services and Software: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostics Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostics Laboratories: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Molecular Diagnostics Market - Country Analysis

  • 11.1 Asia Pacific Molecular Diagnostics Market, Revenue and Forecast to 2030
    • 11.1.1 Overview
      • 11.1.1.1 Asia Pacific Molecular Diagnostics Market by Country
    • 11.1.2 China
      • 11.1.2.1 Overview
    • 11.1.3 China: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.4 China: Molecular Diagnostics Market, by Disease Area
    • 11.1.5 China: Molecular Diagnostics Market, by Technology
      • 11.1.5.1 China: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.6 China:Molecular Diagnostics Market, by Product and Services
    • 11.1.7 China: Molecular Diagnostics Market, by End User
    • 11.1.8 Japan
      • 11.1.8.1 Overview
    • 11.1.9 Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.10 Japan: Molecular Diagnostics Market, by Disease Area
    • 11.1.11 Japan: Molecular Diagnostics Market, by Technology
      • 11.1.11.1 Japan: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.12 Japan: Molecular Diagnostics Market, by Product and Services
    • 11.1.13 Japan: Molecular Diagnostics Market, by End User
    • 11.1.14 India
      • 11.1.14.1 Overview
    • 11.1.15 India: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.16 India: Molecular Diagnostics Market, by Disease Area
    • 11.1.17 India: Molecular Diagnostics Market, by Technology
      • 11.1.17.1 India: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.18 India: Molecular Diagnostics Market, by Product and Services
    • 11.1.19 India: Molecular Diagnostics Market, by End User
    • 11.1.20 Australia
      • 11.1.20.1 Overview
    • 11.1.21 Australia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.22 Australia: Molecular Diagnostics Market, by Disease Area
    • 11.1.23 Australia: Molecular Diagnostics Market, by Technology
      • 11.1.23.1 Australia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.24 Australia: Molecular Diagnostics Market, by Product and Services
    • 11.1.25 Australia: Molecular Diagnostics Market, by End User
    • 11.1.26 South Korea
      • 11.1.26.1 Overview
    • 11.1.27 South Korea: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.28 South Korea: Molecular Diagnostics Market, by Disease Area
    • 11.1.29 South Korea: Molecular Diagnostics Market, by Technology
      • 11.1.29.1 South Korea: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.30 South Korea: Molecular Diagnostics Market, by Product and Services
    • 11.1.31 South Korea: Molecular Diagnostics Market, by End User
    • 11.1.32 Singapore
      • 11.1.32.1 Overview
    • 11.1.33 Singapore: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.34 Singapore: Molecular Diagnostics Market, by Disease Area
    • 11.1.35 Singapore: Molecular Diagnostics Market, by Technology
      • 11.1.35.1 Singapore: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.36 Singapore: Molecular Diagnostics Market, by Product and Services
    • 11.1.37 Singapore: Molecular Diagnostics Market, by End User
    • 11.1.38 Malaysia
      • 11.1.38.1 Overview
    • 11.1.39 Malaysia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.40 Malaysia: Molecular Diagnostics Market, by Disease Area
    • 11.1.41 Malaysia: Molecular Diagnostics Market, by Technology
      • 11.1.41.1 Malaysia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.42 Malaysia: Molecular Diagnostics Market, by Product and Services
    • 11.1.43 Malaysia: Molecular Diagnostics Market, by End User
    • 11.1.44 Philippines
      • 11.1.44.1 Overview
    • 11.1.45 Philippines: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.46 Philippines: Molecular Diagnostics Market, by Disease Area
    • 11.1.47 Philippines: Molecular Diagnostics Market, by Technology
      • 11.1.47.1 Philippines: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.48 Philippines: Molecular Diagnostics Market, by Product and Services
    • 11.1.49 Philippines: Molecular Diagnostics Market, by End User
    • 11.1.50 Thailand
      • 11.1.50.1 Overview
    • 11.1.51 Thailand: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.52 Thailand: Molecular Diagnostics Market, by Disease Area
    • 11.1.53 Thailand: Molecular Diagnostics Market, by Technology
      • 11.1.53.1 Thailand: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.54 Thailand: Molecular Diagnostics Market, by Product and Services
    • 11.1.55 Thailand: Molecular Diagnostics Market, by End User
    • 11.1.56 Indonesia
      • 11.1.56.1 Overview
    • 11.1.57 Indonesia: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.58 Indonesia: Molecular Diagnostics Market, by Disease Area
    • 11.1.59 Indonesia: Molecular Diagnostics Market, by Technology
      • 11.1.59.1 Indonesia: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.60 Indonesia: Molecular Diagnostics Market, by Product and Services
    • 11.1.61 Indonesia: Molecular Diagnostics Market, by End User
    • 11.1.62 Vietnam
      • 11.1.62.1 Overview
    • 11.1.63 Vietnam: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.64 Vietnam: Molecular Diagnostics Market, by Disease Area
    • 11.1.65 Vietnam: Molecular Diagnostics Market, by Technology
      • 11.1.65.1 Vietnam: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.66 Vietnam: Molecular Diagnostics Market, by Product and Services
    • 11.1.67 Vietnam: Molecular Diagnostics Market, by End User
    • 11.1.68 Rest of Asia Pacific
      • 11.1.68.1 Overview
    • 11.1.69 Rest of Asia Pacific: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.70 Rest of Asia Pacific: Molecular Diagnostics Market, by Disease Area
    • 11.1.71 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology
      • 11.1.71.1 Rest of Asia Pacific: Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.72 Rest of Asia Pacific: Molecular Diagnostics Market, by Product and Services
    • 11.1.73 Rest of Asia Pacific: Molecular Diagnostics Market, by End User

12. Asia Pacific Molecular Diagnostics Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Asia Pacific Molecular Diagnostics Market, Key Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Agilent Technologies Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 F. Hoffmann-La Roche Ltd
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Qiagen NV
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 bioMerieux SA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Illumina Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Danaher
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Siemens Healthineers AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Novartis AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 TBG Diagnostics Limited
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Molecular Diagnostics Market Segmentation
  • Table 2. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 3. China:Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 4. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 5. China: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 6. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 7. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
  • Table 8. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
  • Table 9. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 10. Japan: Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Product and Services
  • Table 11. Japan: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 12. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 13. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 14. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 15. India: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 16. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 17. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 18. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 19. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 20. Australia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 21. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 23. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 24. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 25. South Korea: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 26. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 27. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 28. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 29. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 30. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 31. Singapore: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 32. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 33. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 34. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 35. Malaysia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 36. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 37. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 38. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 39. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 40. Philippines: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 43. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 44. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 45. Thailand: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 46. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 47. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 48. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 49. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 50. Indonesia: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 51. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 52. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 53. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 54. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 55. Vietnam: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 56. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 57. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 58. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 59. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 60. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 61. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 62. Organic Developments Done By Companies
  • Table 63. Inorganic Developments Done By Companies
  • Table 64. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

  • Figure 1. Asia Pacific - PEST Analysis
  • Figure 2. Asia Pacific Molecular Diagnostics Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • Figure 6. Oncology: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Infectious Disease: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Genetic Testing: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Cardiac Diseases: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Immune System Disorders: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Asia Pacific Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. RT-PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. qPCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Multiplex PCR: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. DNA Sequencing and Next-Generation Sequencing (NGS): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. DNA microarrays: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. In-Situ Hybridization (ISH): Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Asia Pacific Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 24. Assays and Kits: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Instruments: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Services and Software: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Asia Pacific Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 28. Hospitals and Clinics: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Ambulatory Surgical Centers: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Research and Academic Institutes: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Others: Asia Pacific Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Asia Pacific Molecular Diagnostics Market, By Country, 2022 (US$ Mn)
  • Figure 33. Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 34. China: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 35. Japan: Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. India: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 37. Australia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. South Korea: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 39. Singapore: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Malaysia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 41. Philippines: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 42. Thailand: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. Indonesia: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. Vietnam: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. Rest of Asia Pacific: Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. Growth Strategies Done by the Companies in the Market (%)